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EGF Signaling Patterns the Feather Array
by Promoting the Interbud Fate
that regulate the various parameters in these models
are defined. The prevailing model integrates the mecha-
nisms of reaction-diffusion, lateral inhibition, and the
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Molecular Biology Program propagation of a morphogenetic wave that progresses
Memorial Sloan-Kettering Cancer Center across the field (Jung and Chuong, 2000). It has been
New York, New York 10021 proposed that an early inducing signal originates from
2 Department of Genetics the embryonic midline in the dermis and moves as a
Case Western Reserve University morphogenetic wave to progressively stimulate the
University Hospitals Cleveland overlying epidermis to form placodes, or thickened
Cleveland, Ohio 44106 patches of epithelium (Tanda et al., 1995). Studies on
time determination of feather bud position have revealed
that the morphogenetic wave precedes placode forma-
tion by one row (Davidson, 1983). Consequently, feather
Summary bud development occurs sequentially from the midline
of the dorsal tract, as the temporal development of com-
Feather buds form sequentially in a hexagonal array.
petence closely precedes the morphogenetic wave and
Bone morphogenetic protein (BMP) signaling from the
enables the skin to interpret initial bud-promoting sig-feather bud inhibits bud formation in the adjacent in-
nals mediated by the FGF pathway (Davidson, 1983;terbud tissue, but whether interbud fate and patterning
Jung et al., 1998). Epidermal signals from the placodeis actively promoted by BMP or other factors is un-
stimulate the dermal cells to migrate and condense un-clear. We show that epidermal growth factor (EGF)
der it (Desbiens et al., 1991). Reciprocal and coordinatedsignaling acts positively to establish interbud identity.
interactions between the epidermis and dermis lead toEGF and the active EGF receptor (EGFR) are expressed
the morphogenesis of individual feather buds. In addi-in the interbud regions. Exogenous EGF stimulates
tion to promoting signals, each bud produces an inhibi-epidermal proliferation and expands interbud gene ex-
tory signal that acts to inhibit bud formation in sur-pression, with a concurrent loss of feather bud gene
rounding cells such that each bud is surrounded by aexpression and morphology. Conversely, EGFR inhibi-
region of interbud. This inhibition appears to be medi-tors result in the loss of interbud fate and increased
ated by bone morphogenetic proteins (BMP) and refinedacquisition of feather bud fate. EGF signaling acts di-
by Notch signaling (Crowe et al., 1998; Noramly andrectly on the epidermis and is independent of BMP
Morgan, 1998). Bmp-2 is expressed within the bud andsignaling. The timing of competence to interpret in-
is speculated to transmit an inhibitory signal across sev-terbud-promoting signals occurs at an earlier develop-
eral cells. New buds can form beyond the influence ofmental stage than previously anticipated. These data
the inhibitory signal emanating from the bud. As thedemonstrate that EGFR signaling actively promotes
primary inducing bud signal within the dermis movesinterbud identity.
laterally past the inhibitory zone, the next row of buds
forms. BMP-2 acts early in the process of lateral inhibi-
tion but then is no longer required (Noramly and Morgan,
Introduction 1998). It has been suggested that the bud fate is re-
stricted by another, later mechanism that acts on non-
The developing avian feather bud array is an established placode and placode cells (Noramly and Morgan, 1998).
model system that permits the study of two major pro- Many genes that are expressed within the bud have
cesses in development, cell fate determination, and pat- been characterized to guide the growth and patterning
tern formation. In each tract, the hexagonally positioned of the feather bud. However, genes that reside within
feather bud cells are surrounded by an intervening re- the interbud and actively guide interbud identity and
gion of interbud cells. As the feather array develops, development remain elusive.
there is an exchange of inductive, repressive, and per- EGF is widely known for its role in cell proliferation,
missive signals that guide a cascade of developmental but it is also involved in fate determination and survival.
events culminating in the formation of feather bud and In this study, we have examined the role of EGF signaling
interbud regions. Perturbation in cell fate decisions, pro- in cell fate determination and patterning in the feather
liferation, migration, or cell-cell communication results array. EGF is a ligand for the tyrosine kinase EGF recep-
in changes in the growth and patterning of the feather tor (EGFR) encoded by the erbB1 gene (Olofsson et
bud array. al., 1986). During vertebrate development, EGF and its
The mechanisms that guide establishment of the hex- receptor are expressed and functionally active at sites
agonal feather array are not well understood. Although of epithelial-mesenchymal interactions such as the de-
the overall sequence of interactions necessary for bud
veloping otic vesicle, craniofacial primordia, kidney,
formation has been outlined, only some of the molecules
lung, tooth, and limb (Canoun et al., 1993; Diaz-Ruiz et
al., 1993; Kronmillier et al., 1991; Partanen and Thesleff,
1987). During development of mouse skin, EGF is ex-*Correspondence: l-niswander@ski.mskcc.org
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pressed in the basal keratinocytes of the epidermis and (Figure 1G). If skin was cultured in the presence of 300
ng/ml EGF, activated EGFR was detectable across thethe outer sheath of hair follicles (Partanen and Thesleff,
1987). Transgenic mice that have diminished EGFR sig- entire thickened epidermis (Figure 1H). In skin treated
with AG1478, an inhibitor of EGFR (see below), phos-naling in the skin have aberrant hair follicles (Fowler et
al., 1995). Studies of EGF transgenic and knockout mice phorylated EGFR was undetectable (Figure 1I). Nonspe-
cific staining was minimal with either the phosphorylatedhave only examined the hair follicles at later stages in
development. EGF has been reported to stimulate epi- EGFR antibody or secondary goat anti-mouse antibody,
as seen in control immunostainings (Figure 1J; no sec-thelial cell proliferation and perturb hair and feather bud
growth in explants (Cohen, 1965; Kashiwagi et al., 1997). ondary antibody). These data imply that EGFR signaling
plays an important role in the interbud.These various studies provide some insight into the
complicated regulation of hair follicle development, but
the role of EGF signaling in the developing skin still EGF Signaling Promotes Interbud Fate
remains largely undefined. At HH stage 30, three rows of nascent buds are visible
In the present study, we found that EGF and activated in the dorsal feather tract. Dorsal skin derived from HH
EGFR are expressed in skin prior to formation of the stage 30 was cultured for 3 days in the presence of
epithelial placodes, and then are downregulated in the varying amounts of purified EGF protein (Figure 2). Skin
epidermal placode and maintained in the interbud cultured in the absence of EGF (n  90) recapitulated
through later stages of feather array formation. This sug- the spatial aspects of in vivo feather development (Fig-
gests a role in interbud development and in defining ure 2A). With the finite size of the explant limiting further
boundaries between interbud and bud. We tested the progression, 10–14 rows of feather buds emerge in each
role of EGF signaling during early feather bud develop- explant within 3 days. A 10 ng/ml dose of EGF (n  14)
ment in skin explants (Jung et al., 1998). Treatment with did not significantly perturb bud patterning or out-
exogenous EGF was found to suppress bud formation growth, but the spacing between buds at the lateral
and expand interbud marker expression, whereas EGFR edge was slightly increased (Figures 2B and 2J). At 50
inhibitors caused bud fusions. Localized and shorter ng/ml of EGF, increased interbud spacing was readily
treatment with EGF and EGFR inhibitor to the lateral- observed in the lateral edges of the explant (Figures 2C
most region of the skin perturbs interbud development, and 2J). Higher concentrations of EGF progressively
indicating the lateral tissue is receptive to the interbud- inhibited feather bud formation and outgrowth lateral to
promoting signal. This study suggests that the zone of the preexisting rows from stage 30 skin. At 100 ng/ml
competence to interpret interbud-promoting signals is EGF (n  15), the number of buds was decreased, and
established significantly prior to the advancement of the spacing between buds was significantly increased in the
morphogenetic wave. This indicates that the first step lateral-most rows (Figures 2D and 2J). Interbud spacing
in the acquisition of interbud fate occurs before the was analyzed by calculating the percent interbud area,
known production of inhibitory signals from the placode. and an increase in interbud area correlated with an in-
Our data strongly suggest that EGF signaling plays a crease in the dose of EGF (Figure 2J). At 200 ng/ml (n 
key role in promoting the interbud fate. 15), the two to three rows of preexisting feather buds
were visible, but all other future bud development was
inhibited. Severe inhibition of outgrowth of existing budsResults
was also observed (Figure 2E). At 300 ng/ml EGF (n 
45), the highest concentration used, no new feather budsEGF Signaling Is Localized to the Endogenous Interbud
In order to determine the role of EGF signaling in early were visible, and preexisting feather bud primordia nor-
mally present on stage 30 skin were no longer apparentfeather bud development, the expression of EGF and
the phosphorylated, active form of EGFR was examined. (Figure 2F). Tissue recombination experiments with
stage 31 skin clearly demonstrate that the effect of EGFImmunostaining of stage 32 skin (Hamburger and Hamil-
ton, 1951) with an antibody against EGF revealed the is directly on the epidermis. Epidermis treated for 14 hr
with EGF recombined with untreated dermis led to apresence of EGF in the interbud epidermis and dermis
during early bud development (Figure 1A). EGF expres- loss of new bud formation or scattered feather buds
with large intervening interbud areas (Figure 2I and datasion remained in the interbud throughout early bud de-
velopment (Figure 1B; stage 37 was the latest exam- not shown; n  11). In contrast, EGF-treated dermis
recombined with untreated epidermis (n  8) producedined). An antibody to the phosphorylated form of the
EGFR was used to determine where EGF signaling was buds comparable to the control cultures (n  6; Figures
2H and 2G, respectively). Previous studies have alsoactive. Activated EGFR and EGF were detected in the
lateral developmentally younger preplacode skin of shown that the effect of EGF on the epidermis is direct
and not due to secondary consequences of an initialstage 30–36 skin (Figure 1C and data not shown). As the
epithelial placodes formed, activated EGFR expression effect on the dermis (Cohen, 1965).
Histological analysis of control skin cultures showedwas decreased in the placode compared to the region
adjacent to the placode (Figure 1D). During early bud normal epidermal and dermal arrangement of the feather
bud and interbud (Figure 3A). In contrast, 300 ng/ml EGFstages, activated EGFR was expressed throughout the
interbud region but not in the bud (Figure 1E). In the short led to inhibition of feather bud formation and outgrowth
(Figure 3B), epidermal thickening with invaginationsbud stage (stage 36), active EGFR was most strongly
expressed at the junction of interbud and feather bud (Figure 3B, arrow), and keratinization of subperidermal
layers (Figure 3B, arrowheads). The regular periodic ar-(Figure 1F). A similar expression pattern was seen in
stage 30 skin cultured in control conditions for 3 days rangement of bud and interbud was completely absent.
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Figure 1. EGF and Phosphorylated EGFR Are
Localized in the Interbud Region
EGF protein expression is in the interbud epi-
dermis and dermis (arrows) in the cross-sec-
tion of stage 32 (A) and stage 36 skin (B). The
active form of the EGFR is detectable with a
phosphorylated EGFR-specific antibody (C–I).
Phosphorylated EGFR (Y-EGFR) is detect-
able in skin epidermis prior to placode forma-
tion (C) and then is downregulated in the plac-
ode and maintained in the adjacent epidermis
([D]; arrows mark higher level expression in
the nonplacode epidermis). During dermal
condensation, EGFR is present in the in-
terbud epidermis (arrows) of stage 31 skin
(E). In the short bud stage, phosphorylated
EGFR is detectable in the interbud and near
the interbud-bud junction in stage 36 skin ([F],
arrows) and in skin cultured under control
conditions ([G], arrows). Some staining for
EGF and Y-EGFR is seen in the periderm of
older buds (A, B, F, and G). EGFR is detect-
able throughout the greatly thickened epider-
mis of EGF-treated skin (H) and not visible in
the AG1478-treated skin after 3 days in cul-
ture (I). In controls (no secondary or primary
antibody), no nonspecific staining is ob-
served (J). All pictures were taken at the same
magnification; hatched black lines demarcate
the epidermis (e) and dermis (d).
Our data with purified recombinant EGF at much lower Proliferation profiles are distinctive between the con-
trol and EGF-treated skin. Proliferation in skin was ex-doses confirm results from a previously reported study
using partially purified EGF from the mouse submaxillary amined by incorporation of BrdU. Bud dermis prolifer-
ates significantly more than the interbud dermis (Junggland (Cohen, 1965). Skin treated with 300 ng/ml EGF
was analyzed further for bud identity by examining the and Chuong, 2000). In control cultures, numerous BrdU-
positive proliferating cells were visible in the bud dermisexpression of molecular markers. The bud markers
Bmp-2, Bmp-4, Dermo-1, Fgf-4, and Shh were ex- and epidermis, and relatively less proliferation was seen
in the interbud dermis (n  6; Figure 3G). In skin treatedpressed in control-cultured skin (Figure 3C and data not
shown). In EGF-exposed skin, Bmp-2, Bmp-4, Dermo-1, with EGF for 3 days, the basal keratinocytes in the thick-
ened epidermis and in the invaginations were activelyFgf-4, and Shh expression patterns were severely down-
regulated in the skin within 18 hr (Figure 3D and data proliferating (Figure 3H). The notable decrease in the
dermal proliferation in EGF-treated cultures resemblednot shown). Expression of an interbud marker was also
examined. Collagen I is expressed in the interbud dermis the interbud proliferation profile (n  7). Skin cultures
treated with EGF for shorter time periods yielded similarof developing avian skin (Chuong et al., 1996) and con-
trol culture explant skin (Figure 3E). In EGF-treated skin, results (data not shown). These results demonstrate that
increased and ubiquitous EGF treatment leads to losscollagen I expression was continuous throughout the
dermis (Figure 3F). of bud markers and an expansion of interbud marker.
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Figure 2. EGF Treatment Affects Epidermis and Promotes Interbud Fate
Stage 30 embryonic chick dorsal skin was cultured for 3 days without exogenous EGF (A) or with 10 ng/ml (B), 50 ng/ml (C), 100 ng/ml (D),
200 ng/ml (E), and 300 ng/ml (F) EGF.
(B–D) In 10–100 ng/ml EGF, spacing between buds (rows 3) that form in culture is increased.
(E) In 200 ng/ml EGF, only the specified rows at stage 30 skin are present and stunted. In 300 ng/ml (F), all feather buds are absent. Control
tissue recombination with untreated skin (G) produced buds comparable to dermis treated with EGF (H). Epidermis treated with EGF recombined
with untreated dermis failed to support formation of new feather buds (I). Percent interbud area was calculated (see Experimental Procedures)
from control and EGF-treated explants (J). Pictures were taken at the same magnification.
EGF Signaling Promotes Interbud Fate
235
Figure 3. Characterization of EGF-Induced Interbud
Cross-sections of skin cultured without (A, C, E, and G) or with (B, D, F, and G) 300 ng/ml EGF for 3 days. Sections were stained with
hematoxylin/eosin (A and B). Epidermal invaginations (arrow) and hyperkeratinization (arrowheads) are visible in EGF-treated skin. Loss of
expression of the feather bud marker Shh is evident in EGF-treated skin (D) in comparison to control (C). Interbud marker, collagen I (white
arrows), is present in the interbud dermis of the control skin (E) and in the entire dermis of the EGF-treated skin (F). Proliferating cells were
visualized with antibody against BrdU (white arrows in [G] and [H]). Note the decrease in dermal cell proliferation in EGF-treated skin (H).
Hatched white lines outline the epidermis.
Inhibition of EGFR Signaling Leads to a Loss most often occurred along the medial-lateral axis, and
each row of fused buds was separated by an area ofof Interbud Fate
In order to determine whether EGFR mediates the pro- bud-less skin. Fusions along the anterior-posterior axis
were observed, but at a lower frequency. Preexistingmotion of interbud fate, explant cultures were incubated
with pharmacological inhibitors of the EGFR signaling buds did not fuse but their outgrowth was stunted (Fig-
ure 4C). Similar but less severe effects were obtainedpathways. The EGFR inhibitors AG1478 and ZD1839
block the substrate site of the EGF receptor kinase and with the lower affinity EGFR inhibitor ZD1839 (data not
shown). By blocking one of the downstream EGFR sig-prevent autophosphorylation (Gazit et al., 1991). AG1478
is selective for EGFR at concentrations up to 100 M, naling mediators, the phosphoinositide 3-kinase (PI3K)
pathway, we reproduced feather bud stunting in theand several studies have previously demonstrated the
specificity and effectiveness of AG1478 in the micromo- absence of bud fusions. LY 294002 is a potent and
selective inhibitor of PI3K at concentrations up to 50lar range in organ cultures (Ben-Bassat et al., 1999; Ellis
et al., 2001; Zieske et al., 2000). We performed dose- M, and it acts on the ATP binding site of the enzyme
(Vlahos et al., 1994). Incubation of skin explants with LYresponse studies to determine the effect of blocking
EGF signaling (Figures 1F and 4). Two days after expo- 294002 at 10 M and 50 M (data not shown and Figure
4D, respectively) resulted in stunting of outgrowth with-sure to AG1478, fusions of feather buds were visible
(Figures 4B and 4C, arrow). Fused buds did not have out fusions of the bud. Similar results were obtained with
rapamycin, an inhibitor of mTOR kinase downstream ofany histologically detectable interbud (Figure 4G), and
Shh transcripts were detected in a single continuous PI3 kinase (data not shown). The studies are consistent
with a role for EGF in promoting interbud fate. Theseband across the fused buds (Figure 4H). The fusions
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Table 1. Time Course of Ubiquitous Application of EGF and
EGFR Inhibitor Shows the Temporal Competence of Skin to
Interpret EGFR Signaling
Bud rows 1 2 3 4 5 6
EGF
6 hr    x  
12 hr   x x  
24 hr x x    
3 days  –    
AG1478
6 hr x x x x x fused
12 hr x x x x fused fused
24 hr x x x x fused fused
3 days x x x fused fused fused
, , and x indicate the presence, absence, and stunting of bud
rows, respectively.
studies were also conducted to determine the timing
and reversibility of EGFR signaling effects on interbud
fate and patterning. Skin explants were treated with 300
ng/ml EGF or 50 M EGFR inhibitor AG1478 for various
durations, and then incubated with control media for a
total of 3 days. The results are summarized in Table
1 (n  6–8/condition). With a 6 hr exposure to EGF,
preexisting rows 1 and 2 of buds grew normally (Figure
5B). Row 3, which may be specified but is not visibly
distinguishable at stage 30, remained unperturbed by a
brief exposure to EGF in vitro. However, row 4 was
stunted and patterning was abnormal. Buds in row 5
and lateral to it were inhibited from forming. In a 12 hr
exposure to EGF, rows 1 and 2 grow relatively normally
but rows 3, 4, and 5 are stunted and widely spaced
(Figure 5C). Further lateral rows were inhibited. A 24 hr
exposure to EGF followed by 2 days of recovery in con-
trol media dramatically perturbed patterning and out-
growth of preexisting and any future buds (Figure 5D).
Figure 4. EGFR Signaling Inhibitors Promote Bud Fate Three days of continuous exposure to EGF led to inhibi-
Skin cultured without inhibitors (A), 200 nM AG1478 (B), 50 M tion of preexisting and new feather bud development
AG1478 (C), and 50 M LY 294002 (D) for 3 days. Note the fusions
(Figure 5E).(arrows) in skin cultured with AG1478 (B and C). Bud outgrowth also
Blocking EGFR signaling with AG1478 also perturbedappears stunted. Cross-sections of control skin and AG1478 skin
the proper patterning of bud and interbud regions. Awere stained with hematoxylin/eosin (E–G). In the region of bud
fusion there is no morphologically distinguishable interbud (G). brief 6 or 12 hr exposure led to fusion of the two most
AG1478 (B, C, and F) and LY 294002 (D) both affect bud outgrowth. lateral rows of buds (Figures 5G and 5H, respectively).
Whole-mount in situ hybridization with the feather bud marker Shh After 24 hr of exposure, more medial rows fused together
shows a continuous band of expression in the fused buds (H).
but the preexisting rows did not fuse in culture (Figure
5I). Even a 3 day exposure failed to perturb the bud-
interbud identities of the preexisting rows of stage 30results indicate that the PI3K pathway mediates out-
skin (Figure 5J). The stunting of feather buds occurredgrowth but the interbud-promoting activity is guided by
and remained irreversible after a short exposure of 1–3the non-PI3K arm(s) of the EGFR signaling pathway.
hr to AG1478 (data not shown). These pulse-chase stud-
ies demonstrate the early and irreversible effects of EGF
and EGFR inhibitor. They also demonstrate that theInterbud Competence Resides in Regions of the Skin
Ahead of the Morphogenetic Wave competence to interpret an interbud signal and affect
fate is highest in the lateral regions and is graduallyThe tissue recombination experiments and the increase
in interbud area relative to the increase in dose of EGF repressed toward the midline.
In order to specifically test the regional competencesuggested that EGF exposure was altering the compe-
tence of the skin. To explore this further, we examined of the skin explants, a localized source of EGF or AG1478
was placed at two different positions on the skin. Athe competence of various parts of the skin explant to
interpret the interbud-promoting signal from the EGFR localized source of 50 ng/l EGF was delivered for 4 hr
in the lateral-most region of a stage 30 skin explant (npathway by exposing the skin to ubiquitous or localized
sources of EGF or the EGFR inhibitor AG1478. These 8). After a total of 3 days in culture, buds form in rows
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Figure 5. Localized or Brief Application of EGF and EGFR Inhibitor Demonstrates an Extended Area of Interbud Competence
Skin was cultured for various times with 300 ng/ml EGF (B–E) or 50 M EGFR inhibitor AG1478 (G–J), and then in control media for up to 3
days. Representative bud formation and growth in control cultures (A). EGF treatment over time (B–E) causes progressive loss of new bud
formation, diminished bud outgrowth, and increased spacing between the buds. AG1478 treatment over time (G–J) causes bud fusions,
including the lateral edges of the explants after only a 6 hr exposure to AG1478 (more details are in the Discussion). Twelve hour exposure
to a localized source of 10 mM AG1478 (previous location of source indicated by a dark spot of charcoal) in the lateral region of the explant
leads to bud fusions in the nearby vicinity ([F], arrows). The results of this figure are summarized in Table 1.
1–4 (the prespecified region at the time of treatment), from the bud, inhibiting new bud formation within a dis-
tinct radius of cells. Because EGF and BMP-2 both medi-but more lateral buds do not form (data not shown). A
localized source of 10 mM AG1478 was delivered for 12 ate bud inhibition, it is possible that one signal is the
upstream activator of the second. In the femoral tract,hr in the lateral-most region of the explant (n  12).
After an additional 2.5 days of culture under control Bmp-2 is expressed at low levels in the ectoderm lateral
to the most recently formed row of buds. It then be-conditions, bud fusions occurred around the localized
source (Figure 5F; the source is marked with a piece of comes restricted within sites of future buds, prior to the
appearance of the epidermal placodes (Noramly andcharcoal). In addition, spacing between the buds was
decreased and bud outgrowth inhibited in a larger region Morgan, 1998). However, in the dorsal tract, Bmp-2 is
first visible only within the placode (Jung et al., 1998).around the localized source. When AG1478 was local-
ized along the midline, the treated explants resembled We examined whether EGF treatment for 16, 20, or 24
hr induced Bmp-2 expression in skin explants. We foundcontrol cultures (data not shown). Thus, at stage 30, the
lateral region of the skin far from the midline can be that EGF suppresses the expression of Bmp-2 in the
preexisting buds and that there was no indication ofaltered as to its bud/interbud fate, indicating that it is
competent to interpret interbud-promoting signals via Bmp induction in regions of bud formation (data not
shown). A localized source of EGF also did not induceEGF signaling. Together, the time-dependent and local-
ized source experiments demonstrate the early and irre- Bmp-2 expression (data not shown). Thus, EGF does
not seem to be involved in the endogenous activationversible effects of EGF and EGFR inhibitor. Most impor-
tantly, these studies indicate that interbud competence of Bmp-2 expression. These data suggest that EGF acts
downstream or independently of BMP in the inhibitionresides in regions of the skin previously thought to be
naı¨ve and that interbud fates can be specified at an of bud formation.
In the converse experiment, whole-mount immunohis-earlier time than previously realized.
tochemistry with EGF antibody on skin cultured with
BMP-4 beads did not reveal EGF induction (data notEGF and BMP Act Independently in the Regulation
of Interbud Development shown). As another test, BMP-4 beads were added to
explants cultured in the presence of AG1478 in the me-Finally, we addressed whether EGF may act in concert
with the other described feather bud inhibitors, BMPs. dia (Figures 6A and 6B, n  9 each). In this experiment,
BMP was capable of producing a zone of bud inhibitionNoramly and Morgan (1998) have proposed that BMP-
2 in the early bud primordia plays a role in inhibition of around the bead in the region of AG1478-induced bud
fusions (Figure 6B, arrow). These data indicate thatbud formation. Their model proposes that BMP diffuses
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(HH stage 35–37) were known. Most early interbud mark-
ers are expressed in the bud after early specification.
Collagen I is expressed in the interbud dermis through-
out early bud development. EGF treatment leads to the
expansion of collagen I expression throughout the entire
dermis and an absence of feather bud markers, indicat-
ing a shift in fate to interbud. EGF treatment causes a
decrease in proliferation of bud dermal cells assayed
by BrdU labeling. However, alteration in dermal prolifer-
ation does not affect the competence of the dermis to
Figure 6. BMP-Mediated Bud Inhibition Can Occur in the Absence produce buds as tested in tissue recombination experi-
of EGFR Signaling ments. Interestingly, epidermal cells proliferate rapidly
A BMP-4-soaked bead (1 g/l) was placed on the lateral area of in the EGF-treated cultures, resulting in a thickened epi-
a stage 30 skin explant without EGFR inhibitors (A) and with 50 m dermis with irregularly spaced invaginations. We specu-
AG1478 (B) for 3 days. Note that the zone of inhibition occurs amid
late that these invaginations arise from excess epider-AG1478-induced fusions (arrow).
mal proliferation in the absence of supporting dermal
proliferation.
EGF signaling plays an additional and later role in
BMPs do not require EGF signaling to exert its inhibitory promoting bud growth. Inhibition of EGF signaling
effect on bud formation and suggest that EGF and BMP causes the preexisting buds to be stunted due to de-
act independently to regulate interbud development. creased outgrowth. EGF signaling is present at the bud/
interbud border during this later aspect of bud growth,
suggesting that the EGF signal for bud growth arises atDiscussion
the border of the bud. The importance of localized EGF
signaling is supported by the disrupted outgrowth ofChick embryonic feather buds and interbuds arise in a
preexisting buds following ubiquitous treatment with ei-distinct pattern. However, factors implicated in speci-
ther EGF or EGF inhibitor. The distinct phenotypes ob-fying and/or guiding interbud development have not
tained by exposing skin to the various pharmacologicalbeen reported. The experimental data in this study sup-
inhibitors of EGFR signaling also enable us to separateport a role for EGFR signaling in promoting interbud
the contribution of different branches of the EGFR sig-development and in establishing interbud fate. Prior to
naling pathway to interbud development and budfeather bud development, phosphorylated EGFR (active
growth. Inhibition of EGFR signaling at the level of theform of the receptor) and EGF are expressed in the
EGFR kinase leads to a dose-dependent fusion of thepreplacode skin. Throughout early feather bud develop-
buds and significant stunting of the buds due to de-ment, EGF and active EGFR are expressed in the in-
creased outgrowth. Dermal proliferation in the estab-terbud but not the bud. EGF treatment acts directly on
lished buds of rows 1, 2, and 3 is significantly decreased,
the epidermis (our data and Cohen, 1965) and prevents
whereas newly forming buds in the lateral regions had
new bud formation, which leads to diminished feather
a similar proliferation profile as control skin buds (data
bud marker expression and expansion of interbud
not shown). A subset of the phenotype is observed upon
marker. Conversely, inhibitors of EGF signaling lead to inhibition of the pathway downstream at the level of PI3
bud fusion and loss of interbud tissue. The expression kinase using LY 294002. This inhibitor leads to stunting
pattern data together with the other experiments in this of the buds. Thus, the PI3K arm of the EGFR signaling
report reveal a novel role of the EGF ligand/receptor cascade mediates bud outgrowth, whereas other signal-
system as an important mediator of interbud identity. ing cascades downstream of the EGFR mediate interbud
Our data also indicate that, during later aspects of bud development.
formation, EGF signaling promotes bud growth. Both EGF and BMP inhibit bud development. This
EGFR signaling appears to actively promote interbud suggests that these two factors act in concert to regulate
fate. Our results indicate that EGF is expressed in the bud formation. EGF is expressed in the interbud and
interbud throughout early bud development and that actively promotes interbud development, whereas
it is functionally important for interbud development. Bmp-2 and Bmp-4 are expressed in the bud and inhibit
Increasing doses of EGF increase the area of the in- bud formation in neighboring cells. We tested the rela-
terbud, and at higher doses leads to bud loss with a tionship between these factors and found that EGF does
corresponding gain of interbud fate. Moreover, within not induce Bmp expression and that BMP does not
18 hr of EGF treatment, the bud-promoting factors in- stimulate EGF expression. Therefore, although these
cluding SHH and FGF are negatively regulated. Our stud- factors both regulate interbud development, they ap-
ies are also supported by those of Dohrmann et al. pear to function independently.
(2002), in which they applied an EGF-soaked bead to Experiments in which the skin was treated for short
skin explants. Figure 6A in their paper indicates in- periods demonstrate the early and irreversible effects
creased spacing between buds, bud loss, and stunting of EGF and EGFR inhibitor. More interestingly, they sug-
of buds. Although their results were interpreted differ- gest that the zone of competence is broader than pre-
ently, their results are consistent with ours and provide viously defined. The current understanding of feather
additional evidence for a role for EGF in the specification bud induction relies on a reaction-diffusion mechanism
of interbud fate. Prior to our studies, very few distinct of bud activators and inhibitors combined with a positive
morphogenetic signal that progresses laterally with timemarkers for the interbud of the short feather bud stage
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Experimental Procedures(reviewed in Jung and Chuong, 2000). Studies on explant
cultures have shown that the morphogenetic wave pre-
Explant Culturecedes placode formation by approximately one row (Da-
White Leghorn chicken eggs were obtained from SPAFAS. Explant
vidson, 1983). Fgf-4 and Shh are expressed early in the cultures were performed according to Jung et al. (1998). At the start
placode and promote bud identity. In explant cultures of culture, EGF (R and D Systems), AG1478 (Calbiochem), ZD1839
(kind gift from Neal Rosen), and LY 294002 (kind gift from Ericof skin from HH stage 29-30, an FGF-soaked bead
Holland) were added once, directly to the culture media. BMP-4 (1placed near the primary row can induce bud fusions
g/l) beads were prepared as previously described and placed in(Jung et al., 1998). FGF beads placed in the lateral un-
the lateral areas of the skin explant (Niswander et al., 1993). A local
specified regions fail to elicit fused buds. This suggested source of 10 mM AG1478 or 50 ng/l EGF was delivered in a piece
that unlike the medial regions, the lateral region of the of filter paper placed on the dermal side of the explant for 12 hr.
The filter paper was replaced with a piece of activated charcoal toHH stage 30 skin is not competent to respond to bud
mark the site of application. Proliferation was assessed by incorpo-activators. During normal bud development, Bmp-2 and
ration of BrdU (Sigma). BrdU labeling was accomplished by addingBmp-4 are expressed in the bud placode and mediate
50 ng BrdU/ml of media during the last 2 hr of incubation at 37C.
inhibition of bud in a zone surrounding each bud. BMP4 Buds were visualized by contrast staining with 0.5% Nile blue for
beads can suppress feather bud formation along the 30 s at room temperature and rinsing in PBS. Each experiment
midline or in the lateral regions (Jung et al., 1998). We was repeated at least three times with three to four explants per
condition. Tissue recombinations were done on stage 31-32 skin.have shown in this study that BMP and EGFR signaling
The explant skin was incubated in DMEM plus 2 mg/ml dispasedo not share a common pathway leading to bud inhibi-
plus 20 mM HEPES (pH 7.6) for 10 min on ice. Epidermis and dermistion. Moreover, we show that EGFR signaling is an in- were cultured with EGF (300 ng/ml) for 14 hr. The dermis and epider-
terbud-promoting signal. Our study shows that the skin mis were carefully disassociated with watchmaker forceps. EGF-
is regionally competent to respond to an interbud-pro- treated epidermis or dermis was recombined with untreated dermis
and epidermis, respectively, and cultured for another 3 days in cul-moting signal. When stage 30 skin was exposed to
ture conditions described in Jung et al. (1998).AG1478 for a short duration, bud fusions were observed
in the extreme lateral regions of the explant (Figures 5F
Immunohistochemistryand 5G), significantly ahead of the proposed morphoge-
Skin was fixed flat on polyethylene terephthalate trace-etched mem-netic wave and the area of placode formation. Thus, the
brane in 4% paraformaldehyde in PBS at 4C for 60 min, washedzone of competence to interpret an interbud-promoting
with several changes of PBS, and equilibrated in 30% sucrose at
cue by EGFR signaling resides in a larger area than 4C before embedding for cryosectioning in OCT medium (Fisher).
previously realized. In contrast, bud-promoting signals Immunofluorescent detection of proteins on 10  cryosections was
performed using standard methods (Yamada et al., 1993). For BrdUcan be processed only as the bud-inducing morphoge-
detection, sections were placed in blocking buffer (PBS plus 0.1%netic wave moves laterally.
Triton and 1% heat-treated goat serum) for 15 min and 1 N HCl forEGF activity as assayed by the presence of phosphor-
2 min at 50C before incubating with 6 g/ml monoclonal BrdU
ylated EGFR is observed in the lateral regions (areas in antibody (Roche). Collagen I was detected by using a 1:50 dilution
which the placodes have not yet formed). Based on of M-38 monoclonal antibody (Developmental Studies Hybridoma
Bank) in blocking buffer (PBS plus 0.1% of heat-treated goat serumAG1478 inhibitor studies, EGF signaling is required for
and 1.0% BSA; Chuong et al., 1996). Species-appropriate secondaryinterbud fate in preplacodal skin. This indicates that the
antibodies conjugated to Cy3 (Jackson Immuno Research Labs)capacity to respond to EGF is present and necessary
were used at 1:200 dilution in blocking buffer.
for interbud fate to be established. Moreover, it indicates EGF expression was determined on paraffin sections of skin using
that interbud fate is specified prior to the specification mouse monoclonal anti-EGF (15 g/ml) and phosphorylated EGFR
of bud fate. was detected on cryosections with phospho-Y-1173 anti-EGFR anti-
bodies (1:250; Upstate Biotechnology). Sections were quenched inAs the bud forms, bud-promoting and bud-inhibiting
3% H2O2 in methanol for 10 min and blocked in 1.0% BSA plus 2%signals are produced, which serves to establish the hex-
goat serum before incubating with primary antibody overnight atagonal array of bud and interbud. Thus, the response
4C. Secondary biotinylated goat anti-mouse (Jackson Immuno Re-
to the interbud-promoting signal must be overcome in search Labs) was used at 1:250 for 60 min at room temperature.
areas of bud formation. We find that active EGF signaling Signal was amplified using the ABC kit (Vectastain) and visualized
using DAB.occurs in the preplacode skin and in the interbud region
during and after placode formation. This suggests that
EGF signaling is actively repressed in the bud and main- In Situ Hybridization
Whole-mount in situ hybridization was performed as described pre-tained in the interbud regions.
viously (Henrique et al., 1995), with the exception that treatmentMany issues remain to be resolved, such as the iden-
with 5 g/ml proteinase K for 5 min at room temperature was em-tity of molecules that regulate EGF expression in the
ployed and BM purple substrate (Roche) was used in place of BCIP/
preplacodal skin and interbud; the arm of the EGFR NBT. In situ hybridization to sections was performed as described
signaling pathway that guards interbud identity; and elsewhere (Holmes and Niswander, 2001).
how proliferation of the epidermis and dermis are nor-
mally tightly coordinated. Our study advances an under- Quantitative Measurements of Interbud Area
standing of EGFR signaling in specification of interbud Average interbud area was calculated from enlarged photographs
of seven explants for each dose of EGF. Analysis was done on aidentity. This report also expands the framework within
defined area (42,500 pixels) on either side of the midline lateral towhich we understand determination of fate in the devel-
row 2. Contours of buds were traced and the area was calculatedoping skin. EGFR signaling components are frequently
using Scion Image 1.6a (NIH image). Interbud area was determined
upregulated in a variety of human tumors. Results from by subtracting total bud area from the defined area. Percent interbud
this study contribute to our understanding of the conse- area and standard deviation of percent interbud area between indi-
vidual defined areas was calculated.quences of abnormal EGFR signaling.
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